This Small Technology Transfer Research (STTR) Phase I project will evaluate a rice cell culture system for the production of recombinant gelatin (rGelatin) designed for improved capsule performance. <br/><br/>The commercial application of this project will be on capsule manufacturers serving the pharmaceutical industry. Plant systems used to create rGelatin will offer a lower cost production system compared to other recombinant platforms. Such a recombinant product will be safer than animal-derived gelatin and more acceptable to many consumers. Further, the proposed technology will have the potential to produce customized rGelatin for specific applications.